Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer

Bastiaan M. Privé, Peter H.J. Slootbeek, Babette I. Laarhuis, Samhita Pamidimarri Naga, Maarten J. van der Doelen, Ludwike W.M. van Kalmthout, Bart de Keizer, Samer Ezziddin, Clemens Kratochwil, Alfred Morgenstern, Frank Bruchertseifer, Marjolijn J.L. Ligtenberg, J. Alfred Witjes, Inge M. van Oort, Martin Gotthardt, Sandra Heskamp, Marcel J.R. Janssen, Winald R. Gerritsen, James Nagarajah, Niven Mehra*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

25 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology